IP Library Granted Patent US 7,129,079
Granted Patent B2
US 7,129,079 · App. 10/651,207 · Granted Oct 31, 2006

Cells engineered to contain genes of interest

Assignee: Carnegie Mellon University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,129,079
App. No.
10/651,207
Granted
Oct 31, 2006
Kind
B2
Abstract

Methods and materials are provided for stably introducing any gene into a specific locus in the genome of a microorganism such as yeast without the addition of any drug resistance genes. Specifically provided herein are new genetically engineered inositol-overproducing Saccharomyces cerevisiae strains obtained by using a novel set of yeast integration plasmids that allow the safe, stable, and controlled introduction of homologous as well as heterologous genes into the host genome. In particular, specific loci of the S. cerevisiae yeast genome can be targeted with single or multiple copies of a specific gene that is desired to be expressed or a given set of specific genes that the host can use without the addition of any drug resistance genes. The principles of this new methodology can also be used for the construction of other recombinant yeast and bacterial strains as well as higher eukaryotic cells.

Claims (38)

1. A diploid yeast cell of the genus Saccharomyces with an Opi − phenotype that contains one to six additional integrated functional copies of the INO1 gene, wherein said additional gene copies are inserted into any or all of the target gene mutation loci his3, trp1, and ura3 per haploid genome of said cell wherein said cell does not contain any expressed bacterial sequence.

2. The yeast cell of claim 1 , wherein one additional copy of the INO1 gene is inserted into each of the his3, trp1, and ura3 target gene mutation loci per haploid genome of said cell.

3. A prototrophic diploid yeast cell of the genus Saccharomyces with an Opi − phenotype that contains one to fourteen additional integrated functional copies of the INO1 gene, wherein said additional gene copies are inserted at any or all of fourteen target gene mutation loci per diploid genome.

4. The yeast cell of claim 3 wherein one additional copy of said INO1 gene is inserted at any of said target gene mutation loci per diploid genome of said cell.

5. The yeast cell of claim 3 , wherein said cell does not contain any expressed bacterial sequence.

6. A diploid yeast cell of the genus Saccharomyces with an Opi − phenotype and which contains one to fourteen additional integrated functional copies of the INO1 gene, wherein said additional gene copies are inserted into any or all of the target gene mutation loci ade2, his3, leu2, lys1, met15, trp1, and ura3 per haploid genome wherein said cell does not contain any expressed bacterial sequence.

7. The yeast cell of claim 6 , wherein one additional copy of said INO1 gene is inserted at any of said target gene mutation loci per haploid genome of said cell.

8. A diploid yeast cell of the genus Saccharomyces with an Opi − phenotype and which contains one to twelve additional integrated functional copies of the INO1 gene, wherein said additional gene copies are inserted into any or all of the target gene mutation loci ade2, his3, leu2, lys1, met15, and trp1 per haploid.

9. A diploid yeast cell of the genus Saccharomyces with an Opi − phenotype and which contains five to fourteen additional integrated functional copies of the INO1 gene, wherein said additional gene copies are inserted into any or all of the target gene mutation loci ade2, his3, leu2, lys1, met15, trp1, and ura3 per haploid genome.

10. A haploid yeast cell of the genus Saccharomyces with an Opi − phenotype and which contains one to seven additional integrated functional copies of the INO1 gene, wherein said additional gene copies are inserted into any or all of the target gene mutation loci ade2, his3, leu2, lys1, met15, trp1, and ura3 per haploid genome wherein said cell does not contain any expressed bacterial sequence.

11. The yeast cell of claim 10 , wherein said cell is prototrophic.

12. The yeast cell of claim 10 , wherein one additional copy of said INO1 gene is inserted at any of said target gene mutation loci per haploid genome of said cell.

13. The yeast cell of claim 12 , wherein said cell is prototrophic.

14. A haploid yeast cell of the genus Saccharomyces with an Opi − phenotype and which contains one to six additional integrated functional copies of the INO1 gene, wherein said additional gene copies are inserted into any or all of the target gene mutation loci ade2, his3, leu2, lys1, met15, and trp1 per haploid genome.

15. The yeast cell of claim 14 , wherein said cell is prototrophic.

16. A haploid yeast cell of the genus Saccharomyces with an Opi − phenotype and which contains three to seven additional integrated functional copies of the INO1 gene, wherein said additional gene copies are inserted into any or all of the target gene mutation loci ade2, his3, leu2, lys1, met15, trp1, and ura3 per haploid genome.

17. The yeast cell of claim 16 , wherein said cell is prototrophic.

18. A diploid yeast cell of the genus Saccharomyces that contains one to fourteen additional integrated functional copies of the INO1 gene, wherein said cell does not contain any expressed bacterial sequence.

19. The yeast cell of claim 18 , wherein said cell is prototrophic.

20. A prototrophic diploid yeast cell of the genus Saccharomyces that contains one to fourteen additional integrated functional copies of the INO1 gene.

21. A diploid yeast cell of the genus Saccharomyces that contains five to fourteen additional integrated functional copies of the INO1 gene.

22. A diploid yeast cell containing one to fourteen additional integrated functional copies of a non-lethal gene of interest inserted into any or all of fourteen target gene mutation loci per diploid genome, wherein said cell does not contain any expressed bacterial sequence.

23. The yeast cell of claim 22 , wherein said cell is of the genus Saccharomyces.

24. The yeast cell of claim 23 wherein said genes of interest are inserted into any or all of the target gene mutation loci ade2, his3, leu2, lys1, met15, trp1, and ura3 per haploid genome.

25. The yeast cell of claim 24 , wherein one additional copy of said gene of interest is inserted at any of said target gene mutation loci per haploid genome of said cell.

26. The yeast cell of claim 22 , wherein said cell is prototrophic.

27. A prototrophic diploid yeast cell of the genus Saccharomyces containing one to fourteen additional integrated functional copies of a non-lethal gene of interest inserted into any or all of fourteen different target gene mutation loci per diploid genome.

28. The yeast cell of claim 27 wherein said genes of interest are inserted into any or all of the target gene mutation loci ade2, his3, leu2, lys1, met15, trp1, and ura3 per haploid genome.

29. The yeast cell of claim 28 , wherein one additional copy of said gene of interest is inserted at any of said target gene mutation loci per haploid genome of said cell.

30. A haploid yeast cell containing at least one additional integrated functional copy of a non-lethal gene of interest inserted into any target gene mutation loci per haploid genome wherein said cell does not contain any expressed bacterial sequence.

31. The yeast cell of claim 30 , wherein said cell is of the genus Saccharomyces.

32. The yeast cell of claim 31 , wherein said genes of interest are inserted into any or all of the target gene mutation loci ade2, his3, leu2, lys1, met15, trp1, and ura3 per haploid genome.

33. The yeast cell of claim 32 , wherein one additional copy of said gene of interest is inserted at any of said target gene mutation loci per haploid genome of said cell.

34. The yeast cell of claim 30 , wherein said cell is prototrophic.

35. Inositol-enriched yeast wherein said yeast does not contain any expressed bacterial sequence.

36. Inositol metabolites-enriched yeast wherein said yeast does not contain any expressed bacterial sequence.

37. Inositol phospholipids-enriched yeast wherein said yeast does not contain any expressed bacterial sequence.

38. Phospholipids-enriched yeast wherein said yeast does not contain any expressed bacterial sequence.

Assignments (3)
CONFIRMATORY LICENSE Recorded Nov 8, 2022
From: CARNEGIE-MELON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061897/0065 →
CONFIRMATORY LICENSE Recorded Jun 2, 2021
From: CARNEGIE MELLON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 056413/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2006
From: VILLA, MANUEL J.; HENRY, SUSAN A.
To: CARNEGIE MELLON UNIVERSITY
Reel/Frame 018125/0828 →
Continuity (2)
Division 0967833900 · Oct 3, 2000
Related Publication 20040126873A1 · Jul 1, 2004